Annual report pursuant to Section 13 and 15(d)

Intangible Assets (Details)

v3.8.0.1
Intangible Assets (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Finite-Lived Intangible Assets [Line Items]    
Impairment $ 0 $ 0
Net Carrying Amount 22,069  
Intangible assets subject to amortization [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Amount 36,755 38,443
Accumulated Amortization (14,686) (10,150)
Impairment 0 (1,688)
Net Carrying Amount $ 22,069 $ 26,605
Technology [Member]    
Finite-Lived Intangible Assets [Line Items]    
Useful Life (Years) 10 years 10 years
Gross Amount $ 32,539 $ 32,539
Accumulated Amortization (12,083) (9,069)
Impairment   0
Net Carrying Amount 20,456 23,470
Customer relationships [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Amount 1,984 1,984
Accumulated Amortization (934) (762)
Impairment   0
Net Carrying Amount $ 1,050 $ 1,222
Customer relationships [Member] | Minimum [Member]    
Finite-Lived Intangible Assets [Line Items]    
Useful Life (Years) 9 years 9 years
Customer relationships [Member] | Maximum [Member]    
Finite-Lived Intangible Assets [Line Items]    
Useful Life (Years) 12 years 12 years
Tradename [Member]    
Finite-Lived Intangible Assets [Line Items]    
Useful Life (Years) 3 years 3 years
Gross Amount $ 111 $ 111
Accumulated Amortization (111) (111)
Impairment   0
Net Carrying Amount $ 0 $ 0
MIST Therapy Trade Name [Member]    
Finite-Lived Intangible Assets [Line Items]    
Useful Life (Years) [1] 3 years 3 years
Gross Amount [1] $ 1,913 $ 3,601
Accumulated Amortization [1] (1,350) 0
Impairment [1]   (1,688)
Net Carrying Amount [1] $ 563 $ 1,913
Non-compete [Member]    
Finite-Lived Intangible Assets [Line Items]    
Useful Life (Years) 1 year 1 year
Gross Amount $ 208 $ 208
Accumulated Amortization (208) (208)
Impairment 0 0
Net Carrying Amount $ 0 $ 0
[1] In December 2016, the Company determined the tradename related to MIST Therapy was no longer an indefinite-lived intangible asset. The Company assigned a remaining useful of approximately 1.5 years, consistent with the Company’s other trademarks.